BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:14 PM
 | 
Jan 17, 2007
 |  BC Extra  |  Company News

Archemix, Merck KGaA cancer deal

Archemix ( Cambridge, Mass.) and Merck KGaA (FSE:MRK) partnered to identify and develop aptamer-based therapeutics for...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >